- Home
- BMRN
BMRN
BioMarin Pharmaceutical Inc.
as 01-22-2025 4:00pm EST
| Founded: | 1996 | Country: | United States |
| Employees: | N/A | City: | NOVATO |
| Market Cap: | N/A | IPO Year: | 1999 |
| Target Price: | $94.20 | AVG Volume (30 days): | 1.5M |
| Analyst Decision: | Buy | Number of Analysts: | 21 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 1.68 | EPS Growth: | 118.12 |
| 52 Week Low/High: | $60.63 - $94.85 | Next Earning Date: | 02-20-2025 |
| Revenue: | $2,752,809,000 | Revenue Growth: | 19.14% |
| Revenue Growth (this year): | 18.88% | Revenue Growth (next year): | 10.12% |
Stock Insider Trading Activity of BioMarin Pharmaceutical Inc. (BMRN)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Guyer Charles Greg | BMRN | EVP, Chief Technical Officer | Nov 12 '24 | Sell | $66.37 | 5,278 | $350,323.56 | 68,909 |
Latest BioMarin Pharmaceutical Inc. News
BMRN Breaking Stock News: Dive into BMRN Ticker-Specific Updates for Smart Investing
Zacks
2 days ago
Nanobiotix Stock Gains as Dosing Begins in Mid-Stage NSCLC Study
Simply Wall St.
2 days ago
Earnings are growing at BioMarin Pharmaceutical (NASDAQ:BMRN) but shareholders still don't like its prospects
Insider Monkey
2 days ago
BioMarin Pharmaceutical Inc. (BMRN) Stock: The Under-the-Radar Stock Poised for Massive Upside in 2025
Zacks
2 days ago
Here is Why Growth Investors Should Buy BioMarin (BMRN) Now
Zacks
8 days ago
Zacks Industry Outlook Highlights Incyte, BioMarin, Exelixis, Halozyme and Blueprint Medicines
Argus Research
8 days ago
BMRN: Lowering target price to $51.00
Zacks
9 days ago
5 Biotech Stocks Worth Adding to Your Portfolio in 2025
MT Newswires
9 days ago
BioMarin Pharmaceutical Sues Ascendis Pharma for Alleged Patent Infringement in Germany
Compare BMRN vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BMRN BioMarin Pharmaceutical Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.